Scott F. Huntington

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna et al. · Blood · 2020 · 316 citations · Full text

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study

Scott F. Huntington, Brendan M. Weiss, Dan T. Vogl et al. · The Lancet Haematology · 2015 · 211 citations

Insured Patients, Hematological Malignancy, Financial Toxicity +14

Evolution to plasmablastic lymphoma evades CD19‐directed chimeric antigen receptor T cells

Andrew G. Evans, Paul G. Rothberg, Richard Burack et al. · British Journal of Haematology · 2015 · 105 citations · Full text

R‐<scp>CHOP </scp><i>versus</i> dose‐adjusted R‐<scp>EPOCH</scp> in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis

Nirav N. Shah, Anikó Szabó, Scott F. Huntington et al. · British Journal of Haematology · 2017 · 96 citations · Full text

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Victor M. Orellana‐Noia, Daniel Reed, Ashley McCook et al. · Blood · 2021 · 91 citations · Full text